As an active participant in the fast-changing open medicine landscape, Wolters Kluwer, Health has published a new report titled, “The Path to Open Medicine: Driving Global Health Equity through Medical Research.” The paper defines what open medicine means today and sets forth a vision of how all stakeholders in the space, including funders, institutions, publishers, and researchers, must collaborate to deliver on the collective benefit of medical research and ultimately advance global health equity.
The report is intended to sit within the ongoing global conversation around increased openness in scientific research, including the recent policy guidance issued by the U.S. Office of Science and Technology Policy (OSTP) in August 2022. This measure will ensure key research and data is shared freely and openly across the scientific and healthcare landscapes – contributing to the acceleration of scientific breakthroughs that can help save lives and equip stakeholders, from policymakers to care providers, with the information they need to drive more equitable healthcare.
A call for stakeholder collaboration in medical scholarly research
Wolters Kluwer’s new report asserts that while much progress has been accomplished towards the vision of open medicine, the necessary infrastructure, policies, and practices to truly achieve the mission that the scientific community set for itself more than 20 years ago are still not fully in place. It emphasizes that one of the main barriers is the notion that global health equity can be attained through the actions of a single category of stakeholder.
